According to the Czech Vaccinological Society, exactly 9,750 doses of covid-19 vaccine could arrive in the Czech Republic in two weeks, ie on 28 December. It expects a vaccine from the international pharmaceutical company Pfizer to be approved by the European Union soon.
–
“It simply came to our notice then. The EMA (European Medicines Agency) could issue a permit for Covid Pfizer vaccine as early as 21 December. and 28.12. could be the first 4875 benefits in Prague and 4875 benefits in Brno, “the company said on its profile on the social network Facebook.
–
Vaccines from Pfizer and the German company BioNTech got the green light at the end of last week from the US Food and Drug Administration.
–
Last week, the head of the European Medicines Agency, Emer Cooke, assured MEPs that the speed of approval is important, but not a priority.
–
“We are still performing the same tasks, only quickly in a crisis situation. European Union legislation allows it, “he quoted Medical diary Emer Cooke, who was to emphasize that, unlike in the United Kingdom, where the vaccine was temporarily approved for emergency use, there is a standard marketing authorization process in the EU.
–
A vaccine for almost seven million people
So far, the Ministry of Health has ordered vaccines for the Czechia for two million people, ie four million doses, because it is necessary for everyone to receive two doses.
–
Minister Blatný also stated earlier that the first half a million people should be vaccinated during the first three months of next year.
–
Several manufacturers have to supply the vaccine to the Czech Republic, a total of 6.9 million people are planned to do so. According to the vaccination strategy, the vaccine is expected to be delivered to one million people in the first quarter of 2021, in the second for 2.62 million people, in the third for 2.42 million people and in the fourth for 382,000 people. Additional benefits will be available in 2022. About 40 percent of the population are interested, 20 percent are undecided.
–
Vaccinations should be voluntary and fully covered by public health insurance. According to the strategy, the first will be vaccinated people over the age of 65 and younger patients with serious diseases. According to the latest statistical yearbook, there are over 2.13 million seniors alone, making up one-fifth of the country’s population. Before other applicants are to receive the vaccine, health professionals from selected departments who are more at risk, then other health professionals, employees in social services and critical state infrastructure.
—
